.png)
Agenzia Italiana del Farmaco
Glyptins (antidiabetic drugs), first medicines reclassified from A-PHT Class to A Class - Glyptins (antidiabetic drugs), first medicines reclassified from A-PHT Class to A Class
Glyptins (antidiabetic drugs), first medicines reclassified from A-PHT Class to A Class
With the resolution of 3 May 2024, the Italian Medicines Agency updated the Handbook of Hospital-Local community Care Continuity (PHT) by shifting medicinal products belonging to specific pharmacological classes, from the “A-PHT” classification regime to the “A” class (Offical Gazette, General Series No.108 of 10-05-2024).
In that regard, AIFA’s Scientific and Economic Committee (CSE) has identified glyptins, a category of antidiabetic drugs, as a pharmacological class to be reclassified, since the criteria are met which facilitate access through local pharmacies.
Published on: 13 May 2024
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR